M13 Phage-functionalized Single-walled CNT Probe for Tumor Imaging

Technology #14969

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Image Gallery
Categories
Inventors
Professor Angela Belcher
Department of Materials Science & Engineering, MIT
External Link (be.mit.edu)
Professor Michael Strano
Department of Chemical Engineering, MIT
External Link (srg.mit.edu)
Jifa Qi
Department of Materials Science & Engineering, MIT
Hyungjung Yi
Department of Materials Science & Engineering, MIT
Debadyuti Ghosh
Department of Materials Science & Engineering, MIT
Neelkanth Bardhan
Department of Materials Science & Engineering, MIT
Managed By
Michelle Hunt
MIT Technology Licensing Officer
Patent Protection

Imaging Probe Including Nanoparticle

US Patent Pending US 2013-0230464
Publications
M13 phage-functionalized single-walled carbon nanotubes as nanoprobes for second near-infrared window fluorescence imaging of targeted tumors
Nano Letters, March 14, 2012, p. 1176

Applications

Specific detection and therapy monitoring of tumors, bacterial infections and hard-to-detect areas

Problem Addressed

This technology introduces a new method to address the challenge of non-invasive diagnosis and can be used as a tool for clinical procedures requiring immediate feedback, such as intraoperative surgery.

Technology

In the clinic, non-invasive, real-time and deep tissue imaging greatly facilitates early, accurate diagnoses and surgical procedures. Fluorescence in vivo imaging using second near-infrared (NIR) window light is attractive due to greater penetration of light through tissue. Single-walled carbon nanotubes (SWNTs) show great promise as in vivo imaging agents in the second NIR window, ensuring deeper penetration of light and low autofluorescence. Although SWNTs have previously been used for live cell imaging in vitro and in vivo whole animal imaging, actively targeting in vivo fluorescence imaging has not been achieved, as it is challenging to add targeting moieties to the small coating molecules while keeping the stability of the SWNTs strong enough. Here, multiple capsid proteins of M13 phage were created through independent genetic engineering of M13 phage for in vivo fluorescence imaging of targeted tumors. SWNTs are bound along the length of the phage, while one of the minor coat proteins, p3, of the SWNT-binding phage· is genetically modified to express either peptide ligands or peptide handles for site specific conjugation of antibodies for targeting. By genetically engineering the major coat protein of M13 for stabilizing SWNTs and the minor coat protein for targeting functionality independently, targeting capability was successfully incorporated into the probe without compromising the in vivo stability or the fluorescence of SWNTs.

Advantages

  • Targeting capability is incorporated into the probe without compromising the in vivo stability of the fluorescence of SWNTs.
  • Due to the interchangeability of its components, potentially, any identified targeting ligands or antibody can be readily exchanged onto the imaging probe for molecular recognition of various cancers and bacterial infections.
  • Targeted fluorescence imaging of tumors is in the longer wavelength window, ensuring greater penetration depth and lower tissue autofluorescence.